Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma [Cancer Immunology, Immunotherapy, 63, (2014) 675-683, DOI 10.1007/s00262-014-1545-8]

Ester Simeone, Giusy Gentilcore, Diana Giannarelli, Antonio M. Grimaldi, Corrado Caracò, Marcello Curvietto, Assunta Esposito, Miriam Paone, Marco Palla, Ernesta Cavalcanti, Fabio Sandomenico, Antonella Petrillo, Gerardo Botti, Franco Fulciniti, Giuseppe Palmieri, Paola Queirolo, Paolo Marchetti, Virginia Ferraresi, Gaetana Rinaldi, Maria Pia PistilloGennaro Ciliberto, Nicola Mozzillo, Paolo A. Ascierto

Research output: Contribution to journalComment/debate

Original languageEnglish
Number of pages1
JournalCancer Immunology, Immunotherapy
Volume63
Issue number11
DOIs
Publication statusPublished - 25 Oct 2014

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Cite this

Simeone, E., Gentilcore, G., Giannarelli, D., Grimaldi, A. M., Caracò, C., Curvietto, M., Esposito, A., Paone, M., Palla, M., Cavalcanti, E., Sandomenico, F., Petrillo, A., Botti, G., Fulciniti, F., Palmieri, G., Queirolo, P., Marchetti, P., Ferraresi, V., Rinaldi, G., ... Ascierto, P. A. (2014). Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma [Cancer Immunology, Immunotherapy, 63, (2014) 675-683, DOI 10.1007/s00262-014-1545-8]. Cancer Immunology, Immunotherapy, 63(11). https://doi.org/10.1007/s00262-014-1611-2